1/2 https://jkms.org
To the Editor:
The authors regret that there were errors in (Text/Table 1).
This notice corrects on page 4 and page 5.
1) Text in page 4: The majority patients (n = 4) had gastrointestinal organ involvement, including small bowel and intraperitoneal lymph nodes.
2) Table 1 in page 5: 1,385 in median EBV titer of patient 1.
Content of correction:
Present corrected Text/Table 1.
1) Text in page 4: Three patients had gastrointestinal organ involvement, including small bowel and intraperitoneal lymph nodes.
2) Table 1 in page 5: 13,852 in median EBV titer of patient 1.
J Korean Med Sci. 2020 Jan 13;35(2):e29 https://doi.org/10.3346/jkms.2020.35.e29 eISSN 1598-6357·pISSN 1011-8934
Correspondence
Address for Correspondence:
Hee Gyung Kang, MD, PhD
Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea.
E-mail: [email protected] Yo Han Ahn, MD
Department of Pediatrics, Seoul National University Bundang Hospital, 82 Gumi-ro 173-beon-gil, Bundang-gu, Seongnam 13620, Korea.
E-mail: [email protected]
© 2020 The Korean Academy of Medical Sciences.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://
creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
ORCID iDs Hyesun Hyun
https://orcid.org/0000-0001-8525-1471 Eujin Park
https://orcid.org/0000-0002-4413-468X Myunghyun Cho
https://orcid.org/0000-0002-3237-3173 Sang-Il Min
https://orcid.org/0000-0002-0688-0278 Jongwon Ha
https://orcid.org/0000-0003-2285-3517 Hyoung Jin Kang
https://orcid.org/0000-0003-1009-6002 Hee Young Shin
https://orcid.org/0000-0003-2091-1947
Hyesun Hyun ,
1Eujin Park ,
2Myunghyun Cho ,
3Sang-Il Min ,
4Jongwon Ha ,
4,5Hyoung Jin Kang ,
6Hee Young Shin ,
6Il-Soo Ha ,
3Hae Il Cheong ,
3Yo Han Ahn ,
7and Hee Gyung Kang
31 Department of Pediatrics, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
2 Department of Pediatrics, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
3 Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Korea
4 Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
5 Transplantation Research Institute, Seoul National University College of Medicine, Seoul, Korea
6 Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul, Korea
7Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea
Erratum: Post-Transplant
Lymphoproliferative Diseases in
Pediatric Kidney Allograft Recipients with Epstein-Barr Virus Viremia
► This corrects the article “Post-Transplant Lymphoproliferative Diseases in Pediatric Kidney Allograft Recipients with Epstein-Barr Virus Viremia” in volume 34, number 30, e203.
Il-Soo Ha
https://orcid.org/0000-0001-5428-6209 Hae Il Cheong
https://orcid.org/0000-0001-7556-1265 Yo Han Ahn
https://orcid.org/0000-0002-8185-4408 Hee Gyung Kang
https://orcid.org/0000-0001-8323-5320
2/2 https://jkms.org https://doi.org/10.3346/jkms.2020.35.e29
Table 1. Characteristics of patients with post-transplant lymphoproliferative disease Case
No. Sex/age at time of
PTLD, yr
Primary
disease Time from KT to PTLD,
mon
Presentation Involved sitea Histologic
diagnosis EBV
serostatus Treatment EBV titer, copies/
mL Outcome
Peak Median PTLD Graft
1 F/5 FSGS 10 Fever,
cervical LNE Neck mass, jugular
LNs, portocaval LN Diffuse large B-cell
lymphomab DUK/RUK RTX,
chemotherapy 81,700 13,852 Remission Function
2 F/7 FSGS 6 Vomiting,
abdominal pain Cervical, axillary, inguinal LNs, stomach, small bowel, umbilicus,
vagina
Diffuse large B-cell
lymphomab DUK/R− RTX,
chemotherapy 166,571 587 Remission Function
3 F/14 FSGS 5 Epigastric pain,
poor oral intakeStomach, duodenum,
mesenteric nodules Diffuse large B-cell
lymphomab D+/R− RTX,
chemotherapy 152,987 1,133 Remission Lost
4 M/18 FSGS 3 Head and neck
LNE Cervical LNs Polymorphic typeb DUK/R− RTX 555 555 Remission Function
5 F/7 Congenital
NS 8 Tonsillar
hypertrophy Bilateral tonsils,
cervical LNs Early lesionb DUK/R− RTX 52,135 6,081 Remission Function
6 M/4 Bilateral
MCDK 10 Fever,
cervical LNE Cervical LNs Polymorphic typeb D+/R− RTX 134,159 208,947 Remission Function
7 F/15 Fraiser
syndromec 99 Diarrhea, abdominal mass with tenderness
Perigastric, mesenteric LNs, stomach, small bowel
Burkitt lymphomab DUK/R− RTX,
chemotherapy 315,080 86,642 Remission Function PTLD = post-transplant lymphoproliferative disease, KT = kidney transplantation, EBV = Epstein-Barr virus, F = female, FSGS = focal segmental
glomerulosclerosis, LNE = lymph node enlargement, LN = lymph node, D/R = donor/recipient, UK = unknown, RTX = rituximab, M = male, NS = nephrotic syndrome, MCDK = multicystic dysplastic kidney.
aLesion detected by imaging study (computed tomography or positron emission tomography); bEBV in-situ hybridization positive; cGenetic disorder caused by WT1 mutation.
